We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Opdualag
Australian Public Assessment Report
Device/Product Name
Opdualag
Active ingredients
Nivolumab and Relatlimab
AusPAR Date
Published
Submission Number
PM 2021-03689-1-4
Submission Type
New combination
Decision
Approved